Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000033

Chief Financial Officer gave up 1,927 shares (to pay taxes)

  • Chief Financial Officer acquired 5,893 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hirsch Andrew · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-04-22 Exercise or conversion : show line 1 in the form +5,893 26,199 D
2020-04-22 Shares withheld for taxes : show line 2 in the form −1,927 $45.91 $88,469 24,272 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-04-22 Exercise or conversion : show line 3 in the form Restricted stock units −5,893 11,785 D
Loading xslF345X03/wf-form4_158775877429935.xml…